ADVISORY, June 8, 2012 (GLOBE NEWSWIRE) -- What: Chembio Diagnostics Inc. [CEMI] will visit the NASDAQ MarketSite in Times Square. Chembio Diagnostics Inc. develops, manufactures, licenses and markets point-of-care (POC) diagnostic tests and technology for the detection of infectious diseases, which began trading on NASDAQ June 7, 2012.
